UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apatinib (YN968D1) Reverses Multidrug Resistance by inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (20), p.7981-7991

2010

Volltextzugriff (PDF)

Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

Experimental & molecular medicine, 2017-03, Vol.49 (3), p.e303-e303

2017

Volltextzugriff (PDF)

Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia

Frontiers in oncology, 2023-06, Vol.13, p.1117096-1117096

2023

Volltextzugriff (PDF)

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo

Acta pharmaceutica Sinica. B, 2020-05, Vol.10 (5), p.799-811

2020

Volltextzugriff (PDF)

Monofunctional Platinum (PtII) Compounds - Shifting the Paradigm in Designing New Pt-based Anticancer Agents

Current medicinal chemistry, 2016-05, Vol.23 (12), p.1268-1285

2016

Volltextzugriff (PDF)

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo

Acta pharmaceutica Sinica. B, 2021-07, Vol.11 (7), p.1885-1902

2021

Volltextzugriff (PDF)

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo

Molecular therapy. Oncolytics, 2022-03, Vol.24, p.636-649

2022

Volltextzugriff (PDF)

Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

Experimental and Molecular Medicine, 2020, 52(0), , pp.1-2

2020

Volltextzugriff (PDF)

PCI29732, a Bruton’s Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells

Cellular physiology and biochemistry, 2018-08, Vol.48 (6), p.2302-2317

2018

Volltextzugriff (PDF)

Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

Frontiers in oncology, 2017-11, Vol.7, p.288-288

2017

Volltextzugriff (PDF)

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis

Gut, 2023-12, Vol.72 (12), p.2272-2285

2023

Volltextzugriff (PDF)

Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function

PloS one, 2009-04, Vol.4 (4), p.e5172

2009

Volltextzugriff (PDF)

Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.58-65

2017

Volltextzugriff (PDF)

Intestinal absorption and hepatic elimination of drugs in high‐fat high‐cholesterol diet‐induced non‐alcoholic steatohepatitis rats: exemplified by simvastatin

British journal of pharmacology, 2021-02, Vol.178 (3), p.582-599

2021

Volltextzugriff (PDF)

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

Molecular cancer therapeutics, 2016-08, Vol.15 (8), p.1845-1858

2016

Volltextzugriff (PDF)

Polyoxypregnane steroids with an open-chain sugar moiety from Marsdenia tenacissima and their chemoresistance reversal activity

Phytochemistry (Oxford), 2016-06, Vol.126, p.47-58

2016

Volltextzugriff (PDF)

Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem-like Cells

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (16), p.4431-4445

2014

Volltextzugriff (PDF)

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo

Cell communication and signaling, 2024-06, Vol.22 (1), p.325-15

2024

Volltextzugriff (PDF)

Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo

Oncotarget, 2014-12, Vol.5 (23), p.11971-11985

2014

Volltextzugriff (PDF)

Reversal of ABCB1-related multidrug resistance by ERK5-IN-1

Journal of experimental & clinical cancer research, 2020-03, Vol.39 (1), p.50-50, Article 50

2020

Volltextzugriff (PDF)

Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein

British journal of pharmacology, 2012-07, Vol.166 (5), p.1669-1683

2012

Volltextzugriff (PDF)

MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing

Drugs and drug candidates, 2023-07, Vol.2 (3), p.591-623

2023

Volltextzugriff (PDF)

Disease Status-Dependent Drug-Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis

Frontiers in pharmacology, 2021-04, Vol.12, p.622040-622040

2021

Volltextzugriff (PDF)

Polyoxypregnane Steroids from the Stems of Marsdenia tenacissima

Journal of natural products (Washington, D.C.), 2014-09, Vol.77 (9), p.2044-2053

2014

Volltextzugriff (PDF)

Small-molecule agents for cancer immunotherapy

Acta pharmaceutica Sinica. B, 2024-03, Vol.14 (3), p.905-952

2024

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(65)
Buchkapitel
(1)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Humans
(32)
Animals
(18)
Antineoplastic Agents - Pharmacology
(18)
Cell Line, Tumor
(16)
Multidrug Resistance
(16)
Pharmacology & Pharmacy
(16)
Mice
(15)
Oncology
(15)
Biological And Medical Sciences
(10)
Drug Resistance
(10)
Medical Sciences
(10)
Female
(9)
Mice, Nude
(9)
Atp-Binding Cassette, Sub-Family B, Member 1 - Metabolism
(8)
Cancer
(8)
Male
(8)
Tumors
(8)
Chemotherapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apatinib (YN968D1) Reverses Multidrug Resistance by inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo

Monofunctional Platinum (PtII) Compounds - Shifting the Paradigm in Designing New Pt-based Anticancer Agents

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo

Correction: Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

PCI29732, a Bruton’s Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells

Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis

Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function

Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat

Intestinal absorption and hepatic elimination of drugs in high‐fat high‐cholesterol diet‐induced non‐alcoholic steatohepatitis rats: exemplified by simvastatin

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

Polyoxypregnane steroids with an open-chain sugar moiety from Marsdenia tenacissima and their chemoresistance reversal activity

Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem-like Cells

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo

Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo

Reversal of ABCB1-related multidrug resistance by ERK5-IN-1

Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein

MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing

Disease Status-Dependent Drug-Herb Interactions: NASH Lowered the Risk of Hepatotoxicity in Rats Coadministered With Simvastatin and Gardenia jasminoides J. Ellis

Polyoxypregnane Steroids from the Stems of Marsdenia tenacissima

Small-molecule agents for cancer immunotherapy

Suchergebnisse filtern